This downregulation was corroborated by reanalyzing CLL, Nalm-6 cell line, and TCGA BRCA short-read datasets with mutant SF3B1. CLL has been shown to contain elevated levels of splicing alterations, regardless of SF3B1 mutation status16,66. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.